Mikhail Blagosklonny is a top scientist who has made significant accomplishments in cancer and aging sectors. He is a renowned oncology professor, and his research work has had a great impact in the field. The Roswell Park Cancer Institute has currently hired Blagosklonny to serve as a professor. The scientist schooled at the First Pavlov State Medical University of St. Petersburg where he graduated with a Ph.D. in experimental medicine and cardiology. He is also a holder of a master’s degree in internal medicine. In 2002, the New York Medical College offed Mikhail and opportunity to serve it as an associate professor. He worked at the institution for a couple of years before joining the Ordway Research Institute to act as a senior scientist. Blagosklonny is highly knowledgeable due to the wealth of experience that he has gained while studying oncology. The primary fields that his research work has focused on include the development of targeted cancer therapies, biogerontology, and anti-aging.
The professor has been hired by Oncotarget and Cell Cycle to serve as an editor-in-chief. He is also a skilled associate editor in research fields such as therapy and cancer biology. Mikhail serves on the editorial council of Cell Differentiation and Death. One of his significant accomplishments is the development of a hypothesis that involves the use of TOR signaling potential in mitigating cancer and aging. He believes that Rapamycin is a possible cure for cancer. Mikhail has also made great contributions in longevity research. Some of the areas that the professor has focused on include cellular biology, clinical investigations, and molecular biology. He has also studied signal transduction, drug resistance, tumor suppressors, anticancer therapeutics, apoptosis, and apoptosis.Mikhail Blagosklonny is a science author and has published a lot of content that educates people on the aging hyperfunction theory. His work also has shade light on cell chemotherapeutics and cyclotherapy. The medical sector appreciates the professor due to his outstanding research.
According to Blagosklonny, Rapamycin has extraordinary properties that make it a potential cure for cancer. He has compiled more than 300 research articles, reviews, and book chapters that focus on oncology. The professor’s outstanding knowledge has enabled him to be hired as an associate editor by organizations such as the American Journal of Pathology, International Journal of Cancer, and PLoS ONE. He has devoted his career to finding a perfect cure for cancer and has been recognized among the world’s successful oncology researchers. Mikhail understands that human life is priceless, and this has motivated him to focus on making the world cancer free.Since 2009, the Roswell Park Cancer Institute has greatly benefited from the studies of Prof. Blagosklonny. The institution has provided a platform for various professionals to come together and discuss how cancer can be cured. Mikhail’s studies show that most aging people have a high possibility of having cancer. He, therefore, believes that the two conditions are linked. According to him, mitigating aging is one of the best ways of preventing cancer.